Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Investing

Nebius stock: to buy or not to buy this AI infrastructure play?

admin by admin
September 30, 2025
in Investing
0
Nebius stock: to buy or not to buy this AI infrastructure play?
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The ongoing surge in the Nebius stock price has led to divisions in Wall Street. Many investors believe that it has more room to grow, while others expect it to crumble, citing its hefty valuation. Consequently, its short interest has jumped to nearly 10%. So, is it safe to buy NBIS stock today?

The case for the Nebius stock

Nebius is a large technology company that operates three core businesses. Toloka AI is a company that provide data labeling and annotation for AI models, while TripleTen is a leading company that provides online bootcamps and training solutions for tech professionals. 

The company also operates Avride, which provides autonomous driving solutions. Still, Nebius is known as a competitor to CoreWeave in that it operates large data centers that are essential in the artificial intelligence space. 

Bulls believe that the Nebius has substantial room to grow as the artificial intelligence industry is still in its infancy. They cite recent reports by companies like Bain and McKinsey which have predicted that the industry will require trillions in spending in the coming years.

Most importantly, bulls cite the recent deal between Nebius and Microsoft as a justification to the bullish outlook. According to the deal, Microsoft will be an anchor client that will spend over $17 billion in the next five years using its New Jersey data center.

This deal means that the company may get more multi-billion clients from companies like Meta Platforms, Anthropic, Perplexity AI, OpenAI, Amazon, and Apple.

The most recent results showed that Nebius business was growing at a substantial rate. Its revenue jumped by 625% YoY to $105 million and the management guided to faster growth, with the annualized run-rate (ARR) expected to end the year at $1.1 billion, higher than the previous guidance of $900 million.

Analysts are also highly bullish on the company in terms of its revenue. The average estimate is that its revenue will hit $155 million this quarter, a $55 million increase from what it made in Q2. 

Analysts see the company’s annual revenue coming in at $576 million, a big increase from the $117 million it made last year. Its revenue will then jump to $1.6 billion next year.

Odds are high that the company will do much better than what analysts expect considering that these estimates did not include the Microsoft deal.

The case against NBIS stock

On the other hand, some analysts believe that the Nebius stock price has more downside to go in the coming weeks.

The main bearish view is that the industry is becoming highly concentrated, a move that will affect its margins in the long term. In addition to CoreWeave, the industry has attracted more companies in the past few months.

Some of the top companies that have come up in the industry are IREN, Core Scientific, Riot Platforms, Cipher Mining, TeraWulf, and Bitfarms.

The other main concern is that it has become a highly overvalued company in the past few months. It has a forward PE ratio of 110, much higher than the sector median of 33. 

Additionally, the company will become highly dilutive as it continues to raise capital to build its data centers as its losses mount. Its loss in the last quarter stood at over $175 million, up from $61 million in the same period last year.

A major risk the company has is its depreciation as the company is now focusing on Nvidia’s Blackwell Ultra GPU. Ultimately, the company will upgrade the GPU, a move that may push it to spend billions of dollars. 

Summary

Nebius stock chart | Source: TradingView

Nebius stock price has jumped this year. While a case can be made to buy it today, chances are that the stock could pull back now that it has become overvalued and overbought. Also, the company could go through mean reversion as it has moved much higher than the historical moving averages.

The post Nebius stock: to buy or not to buy this AI infrastructure play? appeared first on Invezz


Previous Post

Tilray stock price forecast as it faces major headwinds

Next Post

USD/ZAR forecast: Here’s why the South African rand is rallying

Next Post
USD/ZAR forecast: Here’s why the South African rand is rallying

USD/ZAR forecast: Here’s why the South African rand is rallying

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

February 17, 2025
Here’s why the Oscar Health stock price is in a bull run

Here’s why the Oscar Health stock price is in a bull run

0
From tariffs to DOGE, what companies are saying about the impact of MAGA policies

From tariffs to DOGE, what companies are saying about the impact of MAGA policies

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
Here’s why the Oscar Health stock price is in a bull run

Here’s why the Oscar Health stock price is in a bull run

October 7, 2025
Dollar Tree shares slide as Jefferies downgrades stock on rising competition

Dollar Tree shares slide as Jefferies downgrades stock on rising competition

October 7, 2025
Ford stock tumbles 7% after report that Novelis plant fire will disrupt production

Ford stock tumbles 7% after report that Novelis plant fire will disrupt production

October 7, 2025
OpenAI-AMD deal is a bane for Broadcom stock but benefits this one AI stock

OpenAI-AMD deal is a bane for Broadcom stock but benefits this one AI stock

October 7, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Here’s why the Oscar Health stock price is in a bull run

    Here’s why the Oscar Health stock price is in a bull run

    October 7, 2025
    Dollar Tree shares slide as Jefferies downgrades stock on rising competition

    Dollar Tree shares slide as Jefferies downgrades stock on rising competition

    October 7, 2025
    Ford stock tumbles 7% after report that Novelis plant fire will disrupt production

    Ford stock tumbles 7% after report that Novelis plant fire will disrupt production

    October 7, 2025
    OpenAI-AMD deal is a bane for Broadcom stock but benefits this one AI stock

    OpenAI-AMD deal is a bane for Broadcom stock but benefits this one AI stock

    October 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved